does cagrilintide cause nausea Efficacy and safety of co-administered once-weekly 2·4 mg with once-weekly semaglutide 2·4 mg in type 2 diabetes: a multicentre, randomised, double-blind, active-controlled, phase 2 trial Frontiers | Do no harm:

Enrolled women will be visited every week in the period of supplementation and the fieldworker will ask questions about their physical condition, compliance among both study groups and adverse events (AE)

Poor website/communication: If their website looks sketchy, emails go unanswered, or information is vague, look elsewhere

Monitoring for any adverse health effects is also recommended 1

10.1111/apt.15195 73

Even in high-dose supplements, the maximum acceptable level of prussic acid set by EFSA is not reached

Along with this limitation, current approaches are labor intensive, highly dependent on expensive growth factors and not amenable to scaling